|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 |
| (11) | Number of the document | 2751280 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12750601.2 |
| Date of filing the European patent application | 2012-08-28 | |
| (97) | Date of publication of the European application | 2014-07-09 |
| (45) | Date of publication and mention of the grant of the patent | 2016-06-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/066632 |
| Date | 2012-08-28 |
| (87) | Number | WO 2013/030168 |
| Date | 2013-03-07 |
| (30) | Number | Date | Country code |
| 11179500 | 2011-08-31 | EP |
| (72) |
DE HAAS, Sanne, Lysbet, CH
DELMAR, Paul, CH
LAMBRECHTS, Diether, BE
SCHERER, Stefan, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
VIB VZW, Rijvisschestraat 120, 9052 Gent, BE Life Sciences Research Partners VZW, Campus Gasthuisberg Herestraat 49, bus 913, 3000 Leuven, BE |
| (54) | METHOD FOR PREDICTING RISK OF HYPERTENSION ASSOCIATED WITH ANTI-ANGIOGENESIS THERAPY |
| METHOD FOR PREDICTING RISK OF HYPERTENSION ASSOCIATED WITH ANTI-ANGIOGENESIS THERAPY |